Intra-Cellular Therapies ... (ITCI)

NASDAQ: ITCI · Real-Time Price · USD

131.87

0.00 (0.00%)

At close: Apr 01, 2025, 3:59 PM

Intra-Cellular Therapies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	306.95M	147.77M	148.62M	92.36M	60.05M	107.64M	54.95M	37.79M	48.64M
Short-Term Investments	694.12M	350.17M	443.29M	319.97M	597.4M	116.37M	292.58M	426.54M	335.46M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	44.65M	45.91M	86K	86.08K	86.08K	86.08K	78.83K	75.77K	75.77K
Receivables	166.5M	114.02M	75.19M	20.16M	10.76M	n/a	n/a	n/a	94.34K
Inventory	26.28M	11.65M	23.92M	7.95M	7.06M	n/a	n/a	n/a	1.00
Other Current Assets	113.52M	44.19M	46.94M	10.9M	1.4M	n/a	n/a	n/a	n/a
Total Current Assets	1.31B	667.8M	737.96M	467.28M	690.9M	230.32M	355.44M	469.22M	388.2M
Property-Plant & Equipment	14.9M	14.58M	16.74M	22.56M	26.32M	20.51M	1.16M	1.14M	627.61K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	59.55M	60.5M	16.82M	22.64M	26.41M	20.86M	1.77M	2.27M	703.38K
Total Assets	1.37B	728.29M	754.78M	489.92M	717.31M	251.19M	357.21M	471.49M	388.9M
Account Payables	26.07M	11.45M	10.39M	8.69M	5.5M	7.43M	13.96M	6.17M	3.75M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	4.23M	n/a	4.57M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	175.4M	81.12M	40.71M	-522	n/a	n/a	n/a	6.42M	n/a
Total Current Liabilities	205.7M	123.55M	83.24M	53.36M	36.85M	36.22M	36.3M	14.21M	10.53M
Long-Term Debt	12.75M	n/a	n/a	18.67B	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-18.67B	n/a	n/a	3.19M	2.84M	2.87M
Total Long-Term Liabilities	12.75M	13.33M	15.47M	18.67M	23.6M	19.96M	3.19M	2.84M	2.87M
Total Liabilities	218.45M	136.87M	98.71M	72.03M	60.45M	56.18M	39.49M	17.05M	13.4M
Total Debt	16.98M	16.94M	20.04M	25.41M	29.14M	23.14M	n/a	n/a	n/a
Common Stock	11K	10K	9K	8.19K	8.05K	5.55K	5.49K	5.46K	4.33K
Retained Earnings	-1.69B	-1.62B	-1.48B	-1.22B	-937.1M	-710.1M	-562.38M	-407.25M	-309.48M
Comprehensive Income	191K	104K	-4.19M	-363.65K	480.58K	128.32K	-667.76K	-799.22K	-317.24K
Shareholders Equity	1.15B	591.42M	656.07M	417.89M	656.86M	195.01M	317.71M	454.44M	375.5M
Total Investments	694.12M	350.17M	443.29M	319.97M	597.4M	116.37M	292.58M	426.54M	335.46M